NCT03975829 2026-02-13Pediatric Long-Term Follow-up and Rollover StudyNovartisPhase 4 Active not recruiting163 enrolled
NCT03363217 2023-11-27Trametinib for Pediatric Neuro-oncology Patients With Refractory Tumor and Activation of the MAPK/ERK Pathway.St. Justine's HospitalPhase 2 Active not recruiting114 enrolled